- All sections
- C - Chemistrymetallurgy
- C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
- C07F 9/553 - Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
Patent holdings for IPC class C07F 9/553
Total number of patents in this class: 45
10-year publication summary
|
4
|
1
|
3
|
2
|
2
|
4
|
9
|
0
|
2
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ventana Medical Systems, Inc. | 1021 |
4 |
| Board of Regents, The University of Texas System | 5763 |
3 |
| Shanghai Shengdi Pharmaceutical Co., Ltd | 120 |
3 |
| Shanghai Senhui Medicine Co., Ltd. | 68 |
3 |
| Cancer Targeted Technology LLC | 27 |
2 |
| Nour Heart, Inc. | 17 |
2 |
| Otsuka Pharmaceutical Co., Ltd. | 1499 |
2 |
| Suzhou Abogen Biosciences Co., Ltd. | 73 |
2 |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 171 |
2 |
| The Trustees of Columbia University in the City of New York | 3563 |
1 |
| Baylor College of Medicine | 943 |
1 |
| Dalhousie University | 178 |
1 |
| Duk San Neolux Co., Ltd. | 645 |
1 |
| Gilead Sciences, Inc. | 2031 |
1 |
| Hangzhou DAC Biotech Co., Ltd | 102 |
1 |
| Intervet International B.V. | 1281 |
1 |
| Jiangsu Hengyi Pharmaceutical Co., Ltd. | 220 |
1 |
| Morphochem Aktiengesellschaft fuer Kombinatorische Chemie | 3 |
1 |
| Nard Institute, Ltd. | 18 |
1 |
| National University Corporation Nagoya University | 860 |
1 |
| Other owners | 11 |